March 1, 1995Journal of Clinical Oncology
Impact of doxorubicin on survival in advanced ovarian cancer.
Why the study?
Does the addition of doxorubicin improve survival in patients with advanced ovarian cancer?
Population
Patients with advanced ovarian cancer
Comparison
Addition of doxorubicin to ovarian cancer regimens vs Ovarian cancer regimens without doxorubicin
Design
Meta-analysis
Authors
Discussion
Loading...
Member takes
Implication
Supports adding doxorubicin to regimens for advanced ovarian cancer; confirms benefit magnitude similar to platinum.
Structured PICO
Does the addition of doxorubicin improve survival in patients with advanced ovarian cancer?
P
Population
Patients with advanced ovarian cancer
I
Intervention
Addition of doxorubicin to ovarian cancer regimens
C
Comparator
Ovarian cancer regimens without doxorubicin
O
Outcome
Survivalhard clinical
The addition of doxorubicin to standard regimens significantly improves survival in advanced ovarian cancer, with a benefit magnitude similar to platinum.
Cite This Study
A’Hern et al. (1995) studied this question.